Becton Dickinsonvs.Edwards Lifesciences
BDX vs EW · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Becton Dickinson and Edwards Lifesciences are similar in size by market cap; year to date, Becton Dickinson leads (+19.8% vs −1.2%).
Side by side
| BDX | EW | |
|---|---|---|
| Market cap | $49.7B | $48.2B |
| Price | $183.75 | $85.21 |
| Today | +0.5% | +1.2% |
| Return YTD | +19.8% | −1.2% |
| Return 1Y | +19.9% | +11.2% |
| Since June 26, 2026 | +17.8% | −6.1% |
| P/E | 52.7 | 47.9 |
| P/S | 2.4 | 7.4 |
| P/B | 2.0 | 4.5 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Becton DickinsonBDX
Syringes and needles sit at the recognisable end of the range. Becton Dickinson's portfolio is broad, spanning medical consumables alongside diagnostic systems and drug delivery equipment.
Full BDX profile →Edwards LifesciencesEW
Heart valves, delivered by catheter as with TAVR or implanted surgically.
Full EW profile →More BDX & EW comparisons
Other head-to-heads in the Medtech & devices segment.